American Capital Management Inc Gilead Sciences, Inc. Transaction History

American Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $2.51 Million - $3.06 Million	-34,431 Closed	0 $0
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $363,932 - $427,204	-5,115 Reduced 12.93%	34,431 $2.47 Million
Q3 2017 Oct 20, 2017	SELL	$72.11 - $85.47 $126,480 - $149,914	-1,754 Reduced 4.25%	39,546 $3.2 Million
Q2 2017 Apr 19, 2018	SELL	N/A	-2,636 Reduced 6.0%	41,300 $2.92 Million
Q1 2017 Apr 18, 2018	BUY	N/A	43,936	43,936 $2.98 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on American Capital Management Inc with notifications on news.